Rocket One (RKTO) Accounts Payables (2017 - 2026)
Rocket One's (RKTO) quarterly Accounts Payables came in at $1.0 million in Q2 2026, up 1229.56% year-over-year from $75510.0 in Q2 2025, and down 16.2% quarter-over-quarter from $1.2 million in Q1 2026.
Analysis
Rocket One (RKTO) Accounts Payables (2017 - 2026) Analysis & Trends
Rocket One has disclosed Accounts Payables across 10 years of filings, most recently posting $1.0 million for Q2 2026.
- In Q2 2026, Accounts Payables rose 1229.56% year-over-year to $1.0 million; the TTM figure through Jun 2026 stood at $1.0 million (up 1229.56% YoY), while the FY2025 annual figure was $823674.0, up 99.89% from the prior year.
- Accounts Payables came in at $1.0 million for Q2 2026 at Rocket One, down from $1.2 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $1.2 million in Q1 2026 to a low of $35592.0 in Q4 2023.
- Average Accounts Payables over 5 years is $590729.8, with a median of $600035.0 recorded in 2022.
- Year-over-year, Accounts Payables slumped 94.88% in 2023 and jumped 1229.56% in 2026.
- Over 5 years, Accounts Payables stood at $694989.0 in 2022, then tumbled by 94.88% to $35592.0 in 2023, then soared by 1057.76% to $412071.0 in 2024, then soared by 99.89% to $823674.0 in 2025, then rose by 21.89% to $1.0 million in 2026.
- Per Business Quant data, the three most recent Accounts Payables figures were $1.0 million in Q2 2026, $1.2 million in Q1 2026, and $823674.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 2.87 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 674.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 429.50 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 1.16 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 167.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 403.90 Mn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 25.08 Mn |
| 10 | Rocket One | 13.86 Mn | 5.97 Mn | - | 1.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 823,674.00 |
| Sep 30, 2025 | 400,067.00 |
| Jun 30, 2025 | 75,510.00 |
| Mar 31, 2025 | 469,405.00 |
| Dec 31, 2024 | 412,071.00 |
| Sep 30, 2024 | 504,809.00 |
| Jun 30, 2024 | 333,346.00 |
| Mar 31, 2024 | 360,905.00 |
| Dec 31, 2023 | 35,592.00 |
| Sep 30, 2023 | 707,185.00 |
| Jun 30, 2023 | 520,658.00 |
| Mar 31, 2023 | 782,831.00 |
| Dec 31, 2022 | 694,989.00 |
| Sep 30, 2022 | 930,925.00 |
| Jun 30, 2022 | 679,412.00 |
| Mar 31, 2022 | 699,811.00 |
| Dec 31, 2021 | 360,964.00 |
| Sep 30, 2021 | 1.30 Mn |